Design and in vitro evaluation of a new nano-microparticulate system for enhanced aqueous-phase solubility of curcumin

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Guzman Villanueva, Diana ^a,b   El Sherbiny, Ibrahim M ^c,d   Herrera Ruiz, Dea ^b   Smyth, Hugh D C ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^c Mansoura University   (Egypt)

^d ZEWAIL CITY OF SCIENCE AND TECHNOLOGY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CARRAGEENAN; CHITOSAN; CURCUMIN; NANOPARTICLE; GLUCURONIC ACID; HEXURONIC ACID; HYDROGEL; WATER;

AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CROSS LINKING; CURCUMA LONGA; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DESIGN; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; FREEZE DRYING; HEART ARRHYTHMIA; HYDROGEL; HYPERKALEMIA; IN VITRO STUDY; INTESTINE FLUID; MUSCLE WEAKNESS; NANOENCAPSULATION; PARTICLE SIZE; POROSITY; SCANNING ELECTRON MICROSCOPY; STOMACH JUICE; SWELLING; ULTRAVIOLET SPECTROPHOTOMETRY; CHEMISTRY; PH; SOLUBILITY; ULTRASTRUCTURE;

ALGINATES; CARRAGEENAN; CURCUMIN; FREEZE DRYING; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEL; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; WATER;

EID: 84883164561     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/724763     Document Type: Article

References (43)

1. Zhang F., Koh G. Y., Jeansonne D. P., Hollingsworth J., Russo P. S., Vicente G., Stout R. W., Liu Z., A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity. Journal of Pharmaceutical Sciences 2011 100 7 2778 2789 2-s2.0-79955622214 10.1002/jps.22512
2. Wilken R., Veena M. S., Wang M. B., Srivatsan E. S., Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular Cancer 2011 10 12 2-s2.0-79551639050 10.1186/1476-4598-10-12
3. Singh S., Khar A., Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anti-Cancer Agents in Medicinal Chemistry 2006 6 3 259 270 2-s2.0-33744490370 10.2174/187152006776930918
4. Teiten M.-H., Gaascht F., Eifes S., Dicato M., Diederich M., Chemopreventive potential of curcumin in prostate cancer. Genes and Nutrition 2010 5 1 61 74 2-s2.0-77149153999 10.1007/s12263-009-0152-3
5. Yen F.-L., Wu T.-H., Tzeng C.-W., Lin L.-T., Lin C.-C., Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities. Journal of Agricultural and Food Chemistry 2010 58 12 7376 7382 2-s2.0-77953625233 10.1021/jf100135h
6. Davis J. M., Murphy E. A., Carmichael M. D., Zielinski M. R., Groschwitz C. M., Brown A. S., Gangemi J. D., Ghaffar A., Mayer E. P., Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. American Journal of Physiology 2007 292 6 R2168 R2173 2-s2.0-34447536771 10.1152/ajpregu.00858.2006
7. Wang X., Jiang Y., Wang Y., Huang M., Ho C., Huang Q., Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chemistry 2008 108 2 419 424 2-s2.0-38049067071 10.1016/j.foodchem.2007.10.086
8. Begum A. N., Jones M. R., Lim G. P., Morihara T., Kim P., Heath D. D., Rock C. L., Pruitt M. A., Yang F., Hudspeth B., Hu S., Faull K. F., Teter B., Cole G. M., Frautschy S. A., Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics 2008 326 1 196 208 2-s2.0-45749089694 10.1124/jpet.108.137455
9. Epstein J., Sanderson I. R., MacDonald T. T., Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. British Journal of Nutrition 2010 103 11 1545 1557 2-s2.0-77953615306 10.1017/S0007114509993667
10. Singh S., Aggarwal B. B., Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). Journal of Biological Chemistry 1995 270 42 24995 25000 2-s2.0-0029589233 10.1074/jbc.270.50.30235
11. Binion D. G., Otterson M. F., Rafiee P., Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 2008 57 11 1509 1517 2-s2.0-54349091392 10.1136/gut.2008.152496
12. Chen A., Xu J., Activation of PPAR γ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. American Journal of Physiology 2005 288 3 G447 G456 2-s2.0-13844306722 10.1152/ajpgi.00209.2004
13. Rinwa P., Kaur B., Jaggi A. S., Singh N., Involvement of PPAR-gamma in curcumin-mediated beneficial effects in experimental dementia. Naunyn-Schmiedeberg's Archives of Pharmacology 2010 381 6 529 539 2-s2.0-77953230561 10.1007/s00210-010-0511-z
14. Chainani-Wu N., Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). Journal of Alternative and Complementary Medicine 2003 9 1 161 168 2-s2.0-0037291286
15. Chen A. L., Hsu C. H., Lin J. K., Hsu M. M., Ho Y.-F., She T.-S., Ko J.-Y., Lin J.-T., Lin B.-R., Wu M.-S., Yu H.-S., Jee S.-H., Chen G.-S., Chen T.-M., Chen C.-A., Lai M.-K., Pu Y.-S., Pan M.-H., Wang Y.-J., Tsai C.-C., Hsieh C.-Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research B 2001 21 4 2895 2900 2-s2.0-0035174504
16. Lao C. D., Ruffin M. T. IV, Normolle D., Heath D. D., Murray S. I., Bailey J. M., Boggs M. E., Crowell J., Rock C. L., Brenner D. E., Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine 2006 6 10 2-s2.0-33645648062 10.1186/1472-6882-6-10
17. Onoue S., Takahashi H., Kawabata Y., Seto Y., Hatanaka J., Timmermann B., Yamada S., Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. Journal of Pharmaceutical Sciences 2010 99 4 1871 1881 2-s2.0-77949844000 10.1002/jps.21964
18. Anand P., Kunnumakkara A. B., Newman R. A., Aggarwal B. B., Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics 2007 4 6 807 818 2-s2.0-37549051274 10.1021/mp700113r
19. Yallapu M. M., Gupta B. K., Jaggi M., Chauhan S. C., Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. Journal of Colloid and Interface Science 2010 351 1 19 29 2-s2.0-77955873538 10.1016/j.jcis.2010.05.022
20. Ireson C., Orr S., Jones D. J. L., Verschoyle R., Lim C.-K., Luo J.-L., Howells L., Plummer S., Jukes R., Williams M., Steward W. P., Gescher A., Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Research 2001 61 3 1058 1064 2-s2.0-0035114277
21. Shishu S., Gupta N., Aggarwal N., Bioavailability enhancement and targeting of stomach tumors using gastro-retentive floating drug delivery system of Curcumin-"a technical note" AAPS PharmSciTech 2008 9 3 810 813 2-s2.0-57149142402 10.1208/s12249-008-9096-y
22. Cui J., Yu B., Zhao Y., Zhu W., Li H., Lou H., Zhai G., Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. International Journal of Pharmaceutics 2009 371 1-2 148 155 2-s2.0-62749095208 10.1016/j.ijpharm.2008.12.009
23. Thangapazham R. L., Puri A., Tele S., Blumenthal R., Maheshwari R. K., Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. International Journal of Oncology 2008 32 5 1119 1123 2-s2.0-45849083928
24. Bisht S., Feldmann G., Soni S., Ravi R., Karikar C., Maitra A., Maitra A., Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. Journal of Nanobiotechnology 2007 5 1 3 2-s2.0-34248205135 10.1186/1477-3155-5-3
25. Anand P., Nair H. B., Sung B., Kunnumakkara A. B., Yadav V. R., Tekmal R. R., Aggarwal B. B., Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochemical Pharmacology 2010 79 3 330 338 2-s2.0-70449637229 10.1016/j.bcp.2009.09.003
26. Das R. K., Kasoju N., Bora U., Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 2010 6 1 e153 e160 2-s2.0-75149122722 10.1016/j.nano.2009.05.009
27. Dass C. R., Choong P., The use of chitosan formulations in cancer therapy. Journal of Microencapsulation 2008 25 4 275 279 2-s2.0-46649092718 10.1080/02652040801970461
28. Prabaharan M., Review paper: chitosan derivatives as promising materials for controlled drug delivery. Journal of Biomaterials Applications 2008 23 1 5 36 2-s2.0-45749114175 10.1177/0885328208091562
29. Ravi Kumar M. N. V., A review of chitin and chitosan applications. Reactive and Functional Polymers 2000 46 1 1 27 2-s2.0-0009365216
30. Kaş H. S., Chitosan: properties, preparations and application to microparticulate systems. Journal of Microencapsulation 1997 14 6 689 711 2-s2.0-0030830841
31. Prabaharan M., Mano J. F., Chitosan-based particles as controlled drug delivery systems. Drug Delivery 2005 12 1 41 57 2-s2.0-11244281032 10.1080/10717540590889781
32. Poncelet D., Lencki R., Beaulieu C., Halle J. P., Neufeld R. J., Fournier A., Production of alginate beads by emulsification/internal gelation. I. Methodology. Applied Microbiology and Biotechnology 1992 38 1 39 45 2-s2.0-0026442714
33. Mohamadnia Z., Zohuriaan-Mehr M. J., Kabiri K., Jamshidi A., Mobedi H., Ionically cross-linked carrageenan-alginate hydrogel beads. Journal of Biomaterials Science, Polymer Edition 2008 19 1 47 59 2-s2.0-37848999043 10.1163/156856208783227640
34. Augst A. D., Kong H. J., Mooney D. J., Alginate hydrogels as biomaterials. Macromolecular Bioscience 2006 6 8 623 633 2-s2.0-33748321119 10.1002/mabi.200600069
35. Gombotz W. R., Wee S. F., Protein release from alginate matrices. Advanced Drug Delivery Reviews 1998 31 3 267 285 2-s2.0-0344352463 10.1016/S0169-409X(97)00124-5
36. Draget K. I., Skjåk-Bræk G., Smidsrød O., Alginate based new materials. International Journal of Biological Macromolecules 1997 21 1-2 47 55
37. Piyakulawat P., Praphairaksit N., Chantarasiri N., Muangsin N., Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium Diclofenac. AAPS PharmSciTech 2007 8 4 E97 2-s2.0-36849025083 10.1208/pt0804094
38. Santo V. E., Frias A. M., Carida M., Cancedda R., Gomes M. E., Mano J. F., Reis R. L., Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 2009 10 6 1392 1401 2-s2.0-67049117927 10.1021/bm8014973
39. Grenha A., Gomes M. E., Rodrigues M., Santo V. E., Mano J. F., Neves N. M., Reis R. L., Development of new chitosan/carrageenan nanoparticles for drug delivery applications. Journal of Biomedical Materials Research A 2010 92 4 1265 1272 2-s2.0-77349114274 10.1002/jbm.a.32466
40. George M., Abraham T. E., pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs. International Journal of Pharmaceutics 2007 335 1-2 123 129 2-s2.0-33947597037 10.1016/j.ijpharm.2006.11.009
41. El-Sherbiny I. M., Enhanced pH-responsive carrier system based on alginate and chemically modified carboxymethyl chitosan for oral delivery of protein drugs: preparation and in-vitro assessment. Carbohydrate Polymers 2010 80 4 1125 1136 2-s2.0-77950367760 10.1016/j.carbpol.2010.01.034
42. El-Sherbiny I. M., Abdel-Mogib M., Dawidar A. M., Elsayed A., Smyth H. D. C., Biodegradable pH-responsive alginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin. Carbohydrate Polymers 2011 83 3 1345 1354 2-s2.0-78650272586 10.1016/j.carbpol.2010.09.055
43. Kurien B. T., Singh A., Matsumoto H., Scofield R. H., Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay and Drug Development Technologies 2007 5 4 567 576 2-s2.0-35148858532 10.1089/adt.2007.064